Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-019025·CITIGROUP INC
Schedule 13G ownership disclosure
PURETECH HEALTH PLC ORD GBP
Ordinary Shares · CUSIP: G7297M101
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Citigroup Global Markets Limited
Shares: 10,703,044 · Class: 4.5%
- Citigroup Global Markets Holdings Bahamas Limited
Shares: 10,703,044 · Class: 4.5%
- Citigroup Financial Products Inc.
Shares: 10,703,044 · Class: 4.5%
- Citigroup Global Markets Holdings Inc.
Shares: 10,703,044 · Class: 4.5%
- Citigroup Inc.
Shares: 10,703,044 · Class: 4.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-019025
- Form type
- SCHEDULE 13G/A
- Filer
- CITIGROUP INC
- CIK
- CIK 831001
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership